medigraphic.com
SPANISH

MediSan

ISSN 1029-3019 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 02

<< Back Next >>

MediSan 2014; 18 (02)

Spontaneous abstinence in mice treated with Mimosa pudica

Fong LO, Berenguer RCA, Puente ZE, Salas MH
Full text How to cite this article

Language: Spanish
References: 12
Page: 198-204
PDF size: 188.48 Kb.


Key words:

Mimosa pudica, addiction, trial of spontaneous abstinence, morphine.

ABSTRACT

The plant Mimosa pudica (moriviví, as it is commonly known), has been traditionally used as anesthetic, antidepressant, sedative, antialopecic, among other pharmacological properties; however, in the last years its use has become excessive. With the objective of knowing the addictive potential of this plant a trial of spontaneous abstinence was developed in mice of the strain NMRI, carried out during 20 days, for which a dose of 1 000 mg/kg of weight of the decoction of the plant was administered orally twice at day. As negative and positive control water and morphine were used (32 mg/kg of weight intraperitoneally, in both cases). Finally, it was shown that this decoction showed signs of physical dependence and the animals in study showed a decrease of the body weight and an increase of the rectal temperature with regard to the negative control, once the decoction was discontinued. On the other hand, these signs were more significant in the positive control, so that it can be stated that the decoction of the plant Mimosa pudica evidenced signs of physical dependence with the used dose.


REFERENCES

  1. Vogel GH. Drug discovery and evaluation. Safety and pharmacokinetic assays. Germany: Springer; 2006.

  2. Ahmad H, Sehgal S, Mishra A, Gupta R. Mimosa pudica L (Laajvanti): an overview. Pharmacogn Rev. 2012; 6(12): 115–24.

  3. Martín F, Mora L, Laorden M, Milanés M. Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal. Br J Pharmacol. 2011; 163(4): 857-75.

  4. Sun H, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D, et al. Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens. J Neurosci. 2012; 32(48): 17454-64.

  5. Becker GL, Gerak LR, Li JX, Koek W, France CP. Precipitated and conditioned withdrawal in morphine-treated rats. Psychopharmacology (Berl). 2010; 209(1): 85-94.

  6. Katovich MJ, Pitman D, Schechtman O. Role of the adrenal gland in the thermal response to morphine withdrawal in rats. Can J Physiol Pharmacol. 1992; 70(8): 1090-5.

  7. Dong Z, Zhang JT. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell. 2003; 14(9): 3942–51.

  8. El-Harith EA, Hiller A, Ter Meulen U. The effect of administration of glycine and tyrosine on the growth depression caused by mimosine in rats. Z Tierphysiol Tierernahrg Futtermittelkde. 1983; 50: 132-7.

  9. Molina M, Contreras CM, Tellez AP. Mimosa pudica may possess antidepressant actions in the rat. Phytomedicine. 1999; 6: 319–23.

  10. Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol. 2010; 15(2): 169- 84.

  11. Brown CG. The alcohol-withdrawal syndrome. West J Med. 1983l; 138(4): 579–81.

  12. Shen G, Tietz EI. Down- regulation of synaptic GluN2B subunit-containing Nmethyl- D-aspartate receptors: a physiological brake on CA1 neuron α-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid hyperexcitability during benzodiazepine withdrawal. J Pharmacol Exp Ther. 2011; 336(1): 265-73.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MediSan. 2014;18